Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Staaf

Showing results (111-120 of 175) with videos related to

Pageof 18
Sort By:
Breast Cancer Research : BCR|May 13, 2010
High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancerJohan Staaf, Göran Jönsson, Markus Ringnér, et al.
Endocrine-Related Cancer|August 30, 2008
Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinomaJia-Jing Lee, Amy Y M Au, Theodoros Foukakis, et al.
The Journal of Pathology|February 10, 2009
Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesionsKarolin H Hallor, Raf Sciot, Johan Staaf, et al.
Pediatric Diabetes|July 5, 2019
Hyperglucagonemia in youth is associated with high plasma free fatty acids, visceral adiposity, and impaired glucose toleranceHannes Manell, Hjalti Kristinsson, Joel Kullberg, et al.
Molecular Oncology|April 25, 2026
DNA methylation and expression of MAPRE3 affect overall survival of early-stage non-small cell lung cancer patientsChao Chen, Jiancheng Cheng, Ruili Hou, et al.
Frontiers in Oncology|February 11, 2025
RET inhibition overcomes resistance to combined CDK4/6 inhibitor and endocrine therapy in ER+ breast cancerCharlotte K Kindt, Sidse Ehmsen, Sofie Traynor, et al.
Scientific Reports|August 23, 2019
Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical seriesJohan Vallon-Christersson, Jari Häkkinen, Cecilia Hegardt, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 7, 2018
DNA Methylation of <i>LRRC3B</i>: A Biomarker for Survival of Early-Stage Non-Small Cell Lung Cancer PatientsYichen Guo, Ruyang Zhang, Sipeng Shen, et al.
Oncotarget|April 19, 2017
Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancerKajsa Ericson Lindquist, Anna Karlsson, Per Levéen, et al.
Cancer Research|September 6, 2005
Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridizationGöran Jönsson, Tara L Naylor, Johan Vallon-Christersson, et al.
Pageof 18

Showing results (111-120 of 175) with videos related to

Sort By:
Pageof 18
Breast Cancer Research : BCR|May 13, 2010
High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancerJohan Staaf, Göran Jönsson, Markus Ringnér, et al.
Endocrine-Related Cancer|August 30, 2008
Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinomaJia-Jing Lee, Amy Y M Au, Theodoros Foukakis, et al.
The Journal of Pathology|February 10, 2009
Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesionsKarolin H Hallor, Raf Sciot, Johan Staaf, et al.
Pediatric Diabetes|July 5, 2019
Hyperglucagonemia in youth is associated with high plasma free fatty acids, visceral adiposity, and impaired glucose toleranceHannes Manell, Hjalti Kristinsson, Joel Kullberg, et al.
Molecular Oncology|April 25, 2026
DNA methylation and expression of MAPRE3 affect overall survival of early-stage non-small cell lung cancer patientsChao Chen, Jiancheng Cheng, Ruili Hou, et al.
Frontiers in Oncology|February 11, 2025
RET inhibition overcomes resistance to combined CDK4/6 inhibitor and endocrine therapy in ER+ breast cancerCharlotte K Kindt, Sidse Ehmsen, Sofie Traynor, et al.
Scientific Reports|August 23, 2019
Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical seriesJohan Vallon-Christersson, Jari Häkkinen, Cecilia Hegardt, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 7, 2018
DNA Methylation of <i>LRRC3B</i>: A Biomarker for Survival of Early-Stage Non-Small Cell Lung Cancer PatientsYichen Guo, Ruyang Zhang, Sipeng Shen, et al.
Oncotarget|April 19, 2017
Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancerKajsa Ericson Lindquist, Anna Karlsson, Per Levéen, et al.
Cancer Research|September 6, 2005
Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridizationGöran Jönsson, Tara L Naylor, Johan Vallon-Christersson, et al.
Pageof 18